A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity

Mohammadi, M; Jeddi-Tehrani, M; Golsaz-Shirazi, F; Arjmand, M; Torkashvand, F; Bahadori, T; Judaki, MA; Shiravi, F; Zare, HA; Haghighat, FN; Mobini, M; Shokri, F; Amiri, MM

Shokri, F; Amiri, MM (通讯作者),Tehran Univ Med Sci Tehran Prov, Sch Publ Hlth, Dist 6,Pour SinaSt, Tehran 644614155, Iran.

JOURNAL OF IMMUNOTHERAPY, 2023; 46 (4): 121

Abstract

Human epidermal growth factor receptor 2 (HER2) overexpression has been demonstrated in a variety of cancers. Targeted therapy with anti-HER2 monoclon......

Full Text Link